Kim, Hui Kwon
Lee, Sungtae
Kim, Younggwang
Park, Jinman
Min, Seonwoo
Choi, Jae Woo
Huang, Tony P.
Yoon, Sungroh
Liu, David R. http://orcid.org/0000-0002-9943-7557
Kim, Hyongbum Henry http://orcid.org/0000-0002-4693-738X
Funding for this research was provided by:
Foundation for the National Institutes of Health (RM1 HG009490, R01 EB022376, R35 GM118062)
Howard Hughes Medical Institute (David Liu)
National Research Foundation of Korea (2017R1A2B3004198, 2017M3A9B4062403, 2018R1A5A2025079)
Ministry of Health and Welfare (HI17C0676, HI16C1012)
Article History
Received: 20 March 2019
Accepted: 6 December 2019
First Online: 14 January 2020
Competing interests
: The authors declare that Yonsei University has filed a patent based on this work, in which H.K.K. and H.H.K. are the co-inventors (patent no. PCT/KR2019/011166). D.R.L. is a consultant and co-founder of Beam Therapeutics, Prime Medicine, Editas Medicine and Pairwise Plants, which are companies that use genome editing.